Outgoing UNODC resident representative visits Tajik counternarcotics agency

24/12/2014 14:15
Avaz Yuldoshev
Views: 11119

DUSHANBE, December 24, 2014, Asia-Plus -- Outgoing United Nations Office on Drugs and Crime (UNDOC) Resident Representative in Tajikistan, Ali Saryazdi, today met here with Lieutenant-General Rustam Nazarzoda, Director of the Drug Control Agency under the President of Tajikistan (DCA), at the end of his tenure to Tajikistan.

According to the DCA press center, he sides discussed issues related to implementation of projects and programs aiming at combating drug trafficking.

Nazarzoda reportedly expressed gratitude to Mr. Ali Saryazdi for his active contribution to the fight against drug trafficking and UNDOC’s support for development of the Tajik counternarcotics agency.

UNODC presence in Central Asia began in 1993 with the establishment of the UNODC Regional Office for Central Asia in Tashkent, Uzbekistan. Today there are Program Offices in all five Central Asian States and Azerbaijan.

With a traditional emphasis on building capacity in counter-narcotics through technical assistance, UNODC activities in the region link national projects on border control with regional projects developing intelligence analysis systems and joint operations.  These include: the Central Asia Regional Information and Coordination Center in Almaty; precursor chemical control; border liaison office project; national drug control agencies; and intelligence lead policing.  All this work is carried out in close cooperation with national and international partners and donors.

UNODC's relationship with Tajikistan stretches back to the late 1990's with collaboration on the establishment of the national counternarcotics agency, and through furthering the operational capacity of the Tajik border forces.  The current relationship largely focuses on these linked issues, with the aim of supporting law enforcement, capacity building, providing policy and legislation advice to Government institutions, and reducing the spread of drugs.

Comments

News no